0001179110-13-011027.txt : 20130628 0001179110-13-011027.hdr.sgml : 20130628 20130628133603 ACCESSION NUMBER: 0001179110-13-011027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130625 FILED AS OF DATE: 20130628 DATE AS OF CHANGE: 20130628 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HBM Healthcare Investments (Cayman) Ltd. CENTRAL INDEX KEY: 0001232258 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 13940078 BUSINESS ADDRESS: STREET 1: 2454 WEST BAY ROAD, 3RD FLOOR CITY: GRAND CAYMAN STATE: E9 ZIP: 00000 BUSINESS PHONE: 1 345 946 8002 MAIL ADDRESS: STREET 1: P.O BOX 30852 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1204 FORMER NAME: FORMER CONFORMED NAME: HBM BIOVENTURES CAYMAN LTD DATE OF NAME CHANGE: 20030512 4 1 edgar.xml FORM 4 - X0306 4 2013-06-25 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001232258 HBM Healthcare Investments (Cayman) Ltd. CENTENNIAL TOWERS, 3RD FLOOR 2454 WEST BAY ROAD GRAND CAYMAN E9 00000 CAYMAN ISLANDS 0 0 1 0 Common Stock 2013-06-25 4 C 0 280178 A 280178 D Common Stock 2013-06-25 4 C 0 1561317 A 1841495 D Common Stock 2013-06-25 4 P 0 666676 15.00 A 2508171 D Series Four Senior Preferred Stock 0 2013-06-25 4 C 0 280178 0 D Common Stock 280178 0 D Series Five Junior Preferred Stock 0 2013-06-25 4 C 0 1561317 0 D Common Stock 1561317 0 D Each share of issuer's Series Four Senior Preferred Stock converted into 1 share of the issuer's Common Stock on June 25, 2013 pursuant to an election by the holders of a majority of the shares of the issuer's preferred stock in connection with the closing of the issuer's firm commitment underwritten public offerng pursuant to a registration statement on Form S-1 under the Securities Act of 1933, as amended (the "IPO") and had no expiration date. Each share of issuer's Series Five Junior Preferred Stock converted into 1 share of the issuer's Common Stock on June 25, 2013 pursuant to an election by the holders of a majority of the shares of the issuer's preferred stock in connection with the closing of the issuer's IPO and had no expiration date. /s/ Jean-Marc Lesieur, Operations Manager 2013-06-27